Circulating tumor DNA mutation as a prognostic marker in melanoma with brain metastasis.

e21560Background: Prognosis in melanoma with brain metastasis is poor with a median survival of four months and a one-year survival rate of 10–20%. There is an unmet need for surveillance methods t...